ArticleBMC urology2026
Identification of risk factors and construction of a nomogram for predicting postoperative stone recurrence in patients with infective upper urinary tract stones.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundInfection-related upper urinary tract stones (struvite and/or carbonate apatite) are prone to early postoperative recurrence. This study aimed to identify predictors of 6-month recurrence and develop a pragmatic risk-prediction nomogram to support individualized follow-up.
methodsA retrospective single-center study was conducted in 148 patients with infection-related stones confirmed by infrared spectroscopy who underwent surgical removal between January 2019 and December 2023. Patients were randomly allocated to a modeling cohort (n = 104) and a validation cohort (n = 44) using a 7:3 non-stratified split (internal split-sample validation only). Candidate predictors and outcomes were complete for all patients, and no imputation was required. Recurrence within 6 months was defined as new stone formation or a > 2-fold increase in residual fragment size on ultrasound or plain computed tomography (CT). Multivariable logistic regression was used to identify independent predictors and to construct a nomogram. Model performance was assessed using discrimination, calibration, and decision curve analysis.
resultsIn the modeling group, the stone recurrence rate was 44.2% (n = 46/104), while in the validation group it was 70.5% (n = 31/44). Compared to non-recurrence cases, patients in the recurrence group had significantly higher rates of residual stones (72% vs. 22%, P < 0.001), renal atrophy (33% vs. 9%, P = 0.002), and positive urine cultures at six-month follow-up (39% vs. 3%, P = 0.008), as well as higher median CT values [821 HU (IQR 592–1003) vs. 511 HU (IQR 416–864), P = 0.004]. Multivariate logistic regression identified residual stones (OR = 6.19, 95% CI: 2.12–18.08, P = 0.001), positive urine culture during follow-up (OR = 9.71, 95% CI: 1.73–54.41, P = 0.010), and CT value (OR = 1.02, 95% CI: 1.00–1.04, P = 0.026) as independent predictors of recurrence. A nomogram constructed using these three factors showed strong predictive performance, with an area under curve of 0.86 (95% CI: 0.77–0.93) in the modeling group and 0.75 (95% CI: 0.59–0.91) in the validation group. Calibration curves demonstrated good agreement between predicted and observed recurrence risk, and decision curve analysis indicated favorable clinical utility of the model.
conclusionsResidual stones, positive follow-up urine culture, and higher CT attenuation values were identified as independent predictors of early recurrence after surgery for infection-related upper urinary tract stones. The nomogram showed acceptable internal performance but requires external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.